Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we Jubilant Life Sciences has informed that the management of the company shall be meeting investors/ analysts in Mumbai, India on December 17 and 18, 2018 as part of a Non-Deal Roadshow. The company has also submitted details of investor/ analyst meetings scheduled for the same. The schedule may undergo change due to exigencies on the part of Investors/ Analysts/ Company. Further, the company submits the presentation to be used during the meetings.
The above information is a part of company's filings submitted to BSE.
